Carcinoma of the penis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
* B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat)
* B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat)
* C. Invasive Carcinoma of the Penis
* C. Invasive Carcinoma of the Penis
Like many malignancies, penile cancer can spread to other parts of the body. It is usually a primary malignancy, the initial place from which a cancer spreads in the body. Much less often it is a secondary malignancy, one in which the cancer has spread to the penis from elsewhere. The staging of penile cancer is determined by the extent of tumor invasion, nodal metastasis, and distant metastasis.(pathological) The [[AJCC]] staging guidelines are as follows:[http://www.cancer.gov/cancertopics/pdq/treatment/penile/HealthProfessional/page3]
*Stage I - The cancer is moderately or well differentiated and only affects the subepithelial connective tissue.
*Stage II - The cancer is poorly differentiated, affects lymphatics, or invades the corpora or urethra.
*Stage IIIa - There is deep invasion into the penis and metastasis in one lymph node.
*Stage IIIb - There is deep invasion into the penis and metastasis into multiple inguinal lymph nodes
*Stage IV - The cancer has invaded into structures adjacent to the penis, metastasized to pelvic nodes, or distant metastasis is present.


==References==
==References==

Revision as of 18:18, 22 September 2015

Carcinoma of the penis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoma of the Penis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoma of the penis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoma of the penis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoma of the penis pathophysiology

CDC on Carcinoma of the penis pathophysiology

Carcinoma of the penis pathophysiology in the news

Blogs on Carcinoma of the penis pathophysiology

Directions to Hospitals Treating Carcinoma of the penis

Risk calculators and risk factors for Carcinoma of the penis pathophysiology

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine

Pathophysiology

Microscopic Pathology

  • A. Precancerous Dermatologic Lesions
  • B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat)
  • C. Invasive Carcinoma of the Penis

References


Template:WikiDoc Sources